Persistent Asset Partners »

Forte Biosciences shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Forte Biosciences (FBRX) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Forte Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Forte Biosciences held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Forte Biosciences by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $277k 10k 27.27

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Molina Healthcare (MOH)
Anthem (ELV)
Intel Corporation (INTC)
Axt (AXTI)
Terns Pharmaceuticals (TERN)
Sandisk Corp (SNDK)
Abivax Sa Sponsored Ads (ABVX)
Johnson & Johnson (JNJ)
Brightspring Health Svcs (BTSG)
Viking Therapeutics Call Call Option
Viking Therapeutics (VKTX)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Nebius Group Shs Class A (NBIS)

View all positions for Persistent Asset Partners

Top funds holding Forte Biosciences

Federated Investors
Fred Alger Management
OrbiMed Advisors
Affinity Asset Advisors
Vanguard Group
Point72 Asset Management
Cable Car Capital
Adage Capital Partners GP
Woodline Partners
FMR
Ikarian Capital
Millennium Management
AWM Investment Company
Jain Global
Sphera Funds Management

View all funds holding Forte Biosciences